This article provides information regarding the addition of the QW modifier to the following CMS HCPCS codes:

  • 87811 [Infectious agent antigen detection by immunoassay with direct optical (i.e., visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])] and code
  • 87428 [Infectious agent antigen detection by immunoassay technique, (e.g., enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; severe acute respiratory syndrome coronavirus (e.g., SARS-CoV, SARS-CoV-2 [COVID-19]) and influenza virus types A and B].

It is important billing staffs are aware of these changes.

For more information, please contact Marketing, 402-489-1207.

###

TELCOR is an industry leader in the laboratory revenue cycle management and point of care testing markets, providing unparalleled health care software products and services, and exceptional customer support. Our proven implementations are performed by clinically experienced, IT knowledgeable resources who understand each customer’s unique environment.